newsfilter
← Latest News
FDA Approved Drugs·

Approval of Cabometyx, Nda #208692 (Efficacy)

Approval Date: 09/10/2025; Drug Name: Cabometyx, Nda #208692; Active Ingredients: CABOZANTINIB S-MALATE; Company: Exelixis Inc; Submission Status: Approval; Submission Classification: Efficacy; Application Number: 208692

Company
EXELIXIS INC
Keywords
EXELIXIS INC